NSE · Healthcare · Health Information Services
with an average price target of ₹275.00.
| Document | Date |
|---|---|
| Quarterly results · Q1 FY27 TAKE LIMITED – Q1 FY2027 FINANCIAL SUMMARY HEADLINE NUMBERS • Consolidated Revenue from Operations: ₹3,037.33 Lakhs (₹30.37 Crore) in Q1 FY27 vs. ₹0 | 2026-08-11 |
| Quarterly results | 2026-07-03 |
| Quarterly results · Q4 FY26 TAKE SOLUTIONS LIMITED - FINANCIAL SUMMARY HEADLINE NUMBERS • Total Income (FY 2025-26): Rs. 661.75 Lakhs vs Rs. 1,387.48 Lakhs previous year (52% d | 2026-06-22 |
| Quarterly results · Q3 FY26 TAKE SOLUTIONS LIMITED – FINANCIAL SUMMARY Q3 & 9M FY2026 (Period Ended 31 December 2025) --- HEADLINE NUMBERS • Q3 FY2026 Standalone Net Profit: I | 2026-02-14 |
| Quarterly results · Q2 FY26 TAKE SOLUTIONS LIMITED – FINANCIAL SUMMARY Q2 FY2025-26 (Half Year Ended September 30, 2025) --- HEADLINE NUMBERS • Half-year revenue from operatio | 2025-10-27 |
| Annual report FY2025 TAKE SOLUTIONS LIMITED - FY 2024-25 SUMMARY FOR RETAIL INVESTORS HEADLINE NUMBERS • Total Assets: ₹316.62 Mn (down 73% from ₹1,191.77 Mn prior year) | 2025-09-06 |
| Quarterly results | 2025-02-12 |
| Quarterly results | 2025-01-22 |
Readable in the app.
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Take Solutions Limited — free to start.
Google PlayApp StoreData updated 2026-09-18.